Physician
Med Equity Partners, LLC
Med Equity Partners, LLC was paid $1.02M by Medicaid between Apr 2018 and Nov 2024, across 92 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 47% of everything it billed.
33Billing provider infoMED EQUITY PARTNERS, LLC
DELAND, FL 32724
DELAND, FL 32724
33aNPI1093253890assigned 02/01/2017
33bProvider typeFamily Medicine Physician
28Total paid$1.02M
24GClaims270,624
24DCodes billed92
24AFirst – last monthApr 2018 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in Florida
Rank by total paid#55 of 996
Median peer was paid$13K
This provider vs. median77×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,601 | $3K | |
| 2019 | 16,159 | $65K | |
| 2020 | 27,820 | $121K | |
| 2021 | 46,376 | $237K | |
| 2022 | 63,099 | $251K | |
| 2023 | 71,285 | $225K | |
| 2024incomplete | 44,284 | $118K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 47% | 13,605 | 11,467 | $481K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 6,318 | 5,526 | $145K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 9.8% | 1,528 | 1,345 | $100K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 7.3% | 1,311 | 1,147 | $74K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.7% | 751 | 708 | $69K |
| 1159F | 2.6% | 12,850 | 10,758 | $26K | |
| 36415 | Collection of venous blood by venipuncture | 2.2% | 3,678 | 3,374 | $23K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.8% | 511 | 460 | $19K |
| 1036F | <1% | 16,957 | 12,274 | $9K | |
| 3008F | <1% | 22,922 | 16,692 | $9K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 107 | 95 | $7K |
| 1125F | <1% | 3,695 | 3,320 | $6K |
80 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 989 | $6K |
| 1126F | <1% | 11,041 | $6K | |
| 1034F | <1% | 4,112 | $4K | |
| 1158F | <1% | 3,759 | $4K | |
| 87428 | <1% | 130 | $3K | |
| 93000 | <1% | 202 | $3K | |
| 1170F | <1% | 3,888 | $3K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 194 | $3K |
| 1160F | <1% | 12,306 | $2K | |
| 3074F | <1% | 16,344 | $2K | |
| 81002 | <1% | 580 | $2K | |
| 3079F | <1% | 6,636 | $1K | |
| 3078F | <1% | 14,642 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 272 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 37 | $1K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 13 | $964.57 |
| 1220F | <1% | 3,108 | $697.15 | |
| 99401 | <1% | 281 | $578.52 | |
| 0011A | <1% | 29 | $560.00 | |
| 3048F | <1% | 2,668 | $547.79 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 18,358 | $523.36 |
| 3075F | <1% | 3,120 | $490.64 | |
| 1111F | <1% | 1,948 | $469.25 | |
| 1101F | <1% | 4,937 | $431.10 | |
| 3080F | <1% | 1,105 | $417.36 | |
| 3049F | <1% | 1,848 | $412.82 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 56 | $397.20 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 18,595 | $371.30 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 1,112 | $357.54 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 6,085 | $353.20 |
| 3077F | <1% | 1,187 | $299.24 | |
| 3044F | <1% | 2,010 | $285.55 | |
| 0012A | <1% | 17 | $240.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 114 | $166.50 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 16 | $130.58 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 5,038 | $104.10 |
| 99406 | <1% | 43 | $103.19 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 21 | $100.10 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 13 | $89.48 |
| 81025 | <1% | 24 | $89.42 | |
| G8484 | Influenza immunization was not administered, reason not given | <1% | 148 | $80.70 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 18 | $77.65 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 911 | $77.01 |
| 85018 | <1% | 60 | $56.67 | |
| 87070 | <1% | 12 | $55.36 | |
| 3050F | <1% | 1,257 | $51.70 | |
| G8450 | Beta-blocker therapy prescribed | <1% | 568 | $44.16 |
| 3288F | <1% | 439 | $40.18 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | <1% | 879 | $29.47 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | <1% | 3,755 | $28.37 |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | <1% | 1,016 | $28.34 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 6,966 | $0.04 |
| 1157F | <1% | 496 | $0.01 | |
| 1124F | 0% | 1,600 | $0.00 | |
| 1090F | 0% | 3,072 | $0.00 | |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 74 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 3,986 | $0.00 |
| G8506 | Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 496 | $0.00 |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 177 | $0.00 |
| 1494F | 0% | 3,724 | $0.00 | |
| 3015F | 0% | 170 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 2,211 | $0.00 |
| 3046F | 0% | 40 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 290 | $0.00 |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 4,522 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 366 | $0.00 |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 278 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 21 | $0.00 |
| 4274F | 0% | 39 | $0.00 | |
| 3014F | 0% | 79 | $0.00 | |
| 4010F | 0% | 74 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 797 | $0.00 |
| 3061F | 0% | 54 | $0.00 | |
| G8473 | Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed | 0% | 29 | $0.00 |
| 91301 | 0% | 38 | $0.00 | |
| 3017F | 0% | 148 | $0.00 | |
| G8866 | Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal) | 0% | 392 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 263 | $0.00 |
| 3072F | 0% | 19 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLANDRY, MICHAEL (MANAGING PARTNER)